期刊文献+

顶空毛细管气相色谱法测定本芴醇中多种残留溶剂 被引量:3

Determination of Residual Oganic Solvents in Lumefantrine by Headspace Capillary Gas Chromatography
原文传递
导出
摘要 目的 建立测定本芴醇原料药中残留溶剂的顶空毛细管气相色谱法。方法 以DB一624毛细管柱(0.53mm×30m,3.0μm)为色谱柱,氮气为载气,用FID检测器,测定本芴醇原料药中甲醇、乙醇、乙酸乙酯、甲苯、异丙醇和丙酮的残留量(外标法计算)。结果 6种有机溶剂完全分离,浓度在考察范围内与峰面积具有良好的线性关系,r为0.9999~1.0000,平均回收率为99.3%~101.5%,精密度RSD均〈10%,最低检出限为0.173~0.396μg·mL^-1。结论 本法快速、灵敏、准确,能较好地检测本芴醇原料药中有机溶剂残留量,控制产品质量。 OBJECTIVE To establish a method of head-space capillary gas chromatography(GC) for the determination of residual organic solvents in lumefantrine. METHODS Residual organic solvents in lumefantrine were separated on DB-624 capillary column using temperature programming and nitrogen as the carrier gas. The inlet temperature was 200 ℃. FID was used as detector with a temperature of 250 ℃. RESULTS Six residual organic solvents were completely separated. There was a good linearity in the experimental concentration ranges(r=0.999 9-1.000 0). The RSD of precision was less than 10%. The average recovery rate ranged from 99.3% to 101.5%. The detection limits were between 0.173 and 0.396 μg.mL^-1. CONCLUSION The method is rapid, sensitive and accurate, which can be used for quality control for the determination of residual organic solvents in lumefantrine.
出处 《中国现代应用药学》 CAS CSCD 2014年第12期1500-1502,共3页 Chinese Journal of Modern Applied Pharmacy
基金 国家药典委员会全球基金项目(GF2012-45)
关键词 本芴醇 残留溶剂 毛细管气相色谱 顶空进样 lumefantrine residual solvents capillary gas chromatography headspace injection
  • 相关文献

参考文献8

  • 1World Health Organization. Practical Chemotherapy ofMalaria: Report of WHO Scientific Group [R]. Geneva: WHO,1990.
  • 2FALADE C O, OGUNKUNLE O O’ DADA-ADEGBOLA H0,et al. Evaluation of the efficacy and safety ofartemether-lumefantrine in the treatment of acuteuncomplicated Plasmodium falciparum malaria in Nigerianinfants and children [J]. Malar J, 2008(7): 246-254.
  • 3FALADE C, MAKANGA M, PREMJI Z,et al. Efficacy andsafety of artemether-lumefantrine (Coartem) tablets (six-doseregimen) in African infants and children with acute,uncomplicated falciparum malaria [J]. Trans R Soc Trop MedHyg, 2005,99(6): 459-467.
  • 4YEUG S, PONGTAVOMPINYO W, HASTINGS I M, et at.Antimalarial drug resistance, artemisinin-based combinationtherapy,and contribution of modeling to elucidationg policychoices [J]. Am J Trop Med Hyg, 2004,71(Suppl 2):S179-S186.
  • 5CHEN R N. Review on determination of residual organicsolvents in drugs [J]. Chin J Pharm, 1997, 28(6): 275-279.
  • 6罗金文,颜琳琦,李樱红,吴鸳鸯,倪维芳,陶巧凤.HPLC测定化妆品中非法添加的米诺地尔[J].中国现代应用药学,2013,30(6):655-657. 被引量:10
  • 7Ch.P(2010)VolII (中国药典 2010 年版.二部)[S]. 2010:Appendix 63-65.
  • 8ICH Steering Committee. International Conference onHarmonisation of Technical Requirements for Registra. VolQuality(药品注册的国际技术要求.质量部分)[M]. Beijing:people's Medical Publishing House, 2007: 134-136.

二级参考文献2

共引文献9

同被引文献11

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部